BackgroundCancer is a rapidly increasing problem in developing countries. Access, quality and efficiency of cancer services in developing countries must be understood to advance effective cancer control programs. Health services research can provide insights into these areas.DiscussionThis article provides an overview of oncology health services in developing countries. We use selected examples from peer-reviewed literature in health services research and relevant publicly available documents. In spite of significant limitations in the available data, it is clear there are substantial barriers to access to cancer control in developing countries. This includes prevention, early detection, diagnosis/treatment and palliation. There are also substantial limitations in the quality of cancer control and a great need to improve economic efficiency. We describe how the application of health data may assist in optimizing (1) Structure: strengthening planning, collaboration, transparency, research development, education and capacity building. (2) Process: enabling follow-up, knowledge translation, patient safety and quality assurance. (3) Outcome: facilitating evaluation, monitoring and improvement of national cancer control efforts. There is currently limited data and capacity to use this data in developing countries for these purposes.SummaryThere is an urgent need to improve health services for cancer control in developing countries. Current resources and much-needed investments must be optimally managed. To achieve this, we would recommend investment in four key priorities: (1) Capacity building in oncology health services research, policy and planning relevant to developing countries. (2) Development of high-quality health data sources. (3) More oncology-related economic evaluations in developing countries. (4) Exploration of high-quality models of cancer control in developing countries. Meeting these needs will require national, regional and international collaboration as well as political leadership. Horizontal integration with programs for other diseases will be important.

O1-S07.04 Table 1 Prevalences of CT and NG in swingers (M/ F) and MSM systematically screened on three anatomical sites Swinger total N[762 % (n) Swinger M N[386 % (n) Swinger F N[375 % (n) MSM N[597 % (n) CT 7.0% (53) 7.0% (27) 6.9% (26) 9.9% (59) CT urogenital 5.1% (39) 5.2% (20) 5.1% (19) 2.3% (14) CT anorectal 3.8% (29) 2.1% (8) 5.6% (21) 8.2% (49) CT oropharyngeal 0.8% (6) 1.0% (4) 0.5% (2) 1.3% (8) GO 2.6% (20) 2.1% (8) 3.2% (12) 5.0% (30) GO urogenital 0.9% (7) 0.8% (3) 1.1% (4) 1.8% (11) GO anorectal 0.5% (4) 0.3% (1) 0.8% (3) 2.8% (17) GO oropharyngeal 1.6% (12) 1.3% (5) 1.9% (7) 2.7% (16) Conclusion MSM and female swingers have high prevalences of anorectal CT which are often diagnosed without a urogenital infection. Therefore these risk groups need a targeted screening strategies including anorectal testing. The prevalence of oropharyngeal STI is relatively low, but it is often an isolated infection and therefore missed by the current screening strategy.

No abstract

informal credit-based arrangements -and were recruited using snowball and location-based methods in October-December 2010. We used successive logistic regression models to explore determinants of HIV infection among women reporting venue-based sex work (e.g. bars -includes women recruited onsite) and women reporting non-venue based sex work. Results HIV prevalence was significantly higher in venue SW compared to non-venue women (55.5% vs. 41.9%, p < 0.01). Numbers of clients reported were low, but more venue SW reported 2 or more clients in the last fortnight (38% vs. 7.6%, p < 0.01); consistent condom-use during commercial acts was similar (60% and 68%, p > 0.1). More venue SW reported ever travelling away from where they live to sell sex (27% vs. 12%, p < 0.01), initiated sex work earlier (age 25 vs. 28 years, p < 0.01), and sold sex for longer (6 vs. 5 years, p < 0.05). Factors associated with HIV infection were type of sex work (aOR: 2.2, 95% CI: 1.3-3.8 vs. non-venue), and SW not requesting condom-use (aOR: 3.0, 95% CI: 1.15-7.85), after controlling for basic demographic differences. Conclusion Venue SW were more likely to be HIV-positive than non-venue women, although in both groups HIV prevalence was substantial, and consistent condom use low. High risk of HIV among women not requesting condom use highlights the importance to renew prevention efforts in this population. The results emphasise the need to understand SW more broadly.Using ResPondent-dRiven samPling to estimate Hiv and syPHilis PRevalence among Female sex WoRkeRs in agadiR, Fes, Rabat and tangieR, moRocco